- Home
- NEOV vs INO Comparison
NEOV vs INO Comparison
Compare NEOV & INO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | NEOV | INO |
|---|---|---|
| Founded | 2018 | 1979 |
| Country | United States | United States |
| Employees | 17 | N/A |
| Industry | Industrial Machinery/Components | Medical/Dental Instruments |
| Sector | Miscellaneous | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 145.6M | 118.9M |
| IPO Year | N/A | 1999 |
Fundamental Metrics
Financial Performance| Metric | NEOV | INO |
|---|---|---|
| Price | $3.63 | $1.75 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 1 | 5 |
| Target Price | N/A | ★ $9.00 |
| AVG Volume (30 Days) | 532.4K | ★ 804.8K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 35.14 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $42,220,086.00 |
| Revenue This Year | $150.56 | N/A |
| Revenue Next Year | $5.31 | $23,060.18 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 19.37 |
| 52 Week Low | $1.81 | $1.30 |
| 52 Week High | $7.13 | $2.86 |
Technical Indicators
Market Signals| Indicator | NEOV | INO |
|---|---|---|
| Relative Strength Index (RSI) | 49.58 | 52.08 |
| Support Level | $2.89 | $1.72 |
| Resistance Level | $3.78 | $1.78 |
| Average True Range (ATR) | 0.36 | 0.09 |
| MACD | 0.03 | -0.00 |
| Stochastic Oscillator | 70.18 | 28.75 |
Price Performance
Historical ComparisonAbout NEOV NeoVolta Inc.
NeoVolta Inc is engaged in designing, manufacturing and sale of high end Energy Storage System which can store and use solar energy via batteries and an inverter at a residential site. Its market place includes solar industry, installers, new construction homebuilders, home remodelers and homeowners.
About INO Inovio Pharmaceuticals Inc.
Inovio Pharmaceuticals Inc is a United States-based biotechnology company. The company is focused on developing and commercializing DNA medicines to help treat and protect people from HPV-associated diseases, cancer and infectious diseases. The company is engaged in gene therapy, where its immunotherapy platform consists of DNA-based immunotherapy and electroporation delivery technologies.